Logo image of NTB.CA

NEW TYMBAL RESOURCES LTD (NTB.CA) Stock Fundamental Analysis

TSX-V:NTB - TSX Venture Exchange - CA6490171007 - Common Stock - Currency: CAD

0.035  +0.01 (+16.67%)

Fundamental Rating

0

NTB gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. NTB may be in some trouble as it scores bad on both profitability and health. NTB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NTB had negative earnings in the past year.
NTB.CA Yearly Net Income VS EBIT VS OCF VS FCFNTB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -200K -400K -600K

1.2 Ratios

NTB has a Return On Assets of -264.22%. This is amonst the worse of the industry: NTB underperforms 81.58% of its industry peers.
NTB has a Return On Invested Capital of 11.64%. This is amongst the best in the industry. NTB outperforms 96.61% of its industry peers.
Industry RankSector Rank
ROA -264.22%
ROE N/A
ROIC 11.64%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTB.CA Yearly ROA, ROE, ROICNTB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NTB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTB.CA Yearly Profit, Operating, Gross MarginsNTB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

NTB has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for NTB is higher compared to a year ago.
NTB.CA Yearly Shares OutstandingNTB.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M
NTB.CA Yearly Total Debt VS Total AssetsNTB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 1M 2M 3M 4M

2.2 Solvency

Based on the Altman-Z score of -59.73, we must say that NTB is in the distress zone and has some risk of bankruptcy.
NTB's Altman-Z score of -59.73 is on the low side compared to the rest of the industry. NTB is outperformed by 79.88% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -59.73
ROIC/WACCN/A
WACCN/A
NTB.CA Yearly LT Debt VS Equity VS FCFNTB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

NTB has a Current Ratio of 0.71. This is a bad value and indicates that NTB is not financially healthy enough and could expect problems in meeting its short term obligations.
NTB has a Current ratio of 0.71. This is in the lower half of the industry: NTB underperforms 62.67% of its industry peers.
NTB has a Quick Ratio of 0.71. This is a bad value and indicates that NTB is not financially healthy enough and could expect problems in meeting its short term obligations.
NTB has a worse Quick ratio (0.71) than 60.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
NTB.CA Yearly Current Assets VS Current LiabilitesNTB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

NTB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.90%.
EPS 1Y (TTM)-28.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NTB.CA Yearly Revenue VS EstimatesNTB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024
NTB.CA Yearly EPS VS EstimatesNTB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NTB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTB.CA Price Earnings VS Forward Price EarningsNTB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTB.CA Per share dataNTB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NTB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEW TYMBAL RESOURCES LTD

TSX-V:NTB (3/7/2025, 7:00:00 PM)

0.035

+0.01 (+16.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.1%
Ins Owner ChangeN/A
Market Cap627.90K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS-0.26
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -264.22%
ROE N/A
ROCE 16.16%
ROIC 11.64%
ROICexc 11.86%
ROICexgc 11.86%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z -59.73
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.86%
OCF growth 3YN/A
OCF growth 5YN/A